Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 155 of 1,261

  1. US 11827600

    Crystalline forms of trofinetide

    ACADIA Pharmaceuticals Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  2. US 11826325

    Use of Belinostat or pharmaceutically acceptable salt thereof in preparation of drug for treating infection

    The First Affiliated Hospital of Xi'an Jiaotong University · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  3. US 11826328

    Stable treprostinil prodrugs

    United Therapeutics Corporation · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  4. US 11826321

    Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions

    TONIX PHARMA LIMITED · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  5. US 11826322

    Pre-filled syringe

    Teva Pharmaceuticals USA, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  6. US 11826327

    Treatment for interstitial lung disease

    United Therapeutics Corporation · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  7. US 11826373

    Methods for treatment of diseases

    Galera Labs, LLC · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  8. US 11826370

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  9. US 11826429

    Pharmaceutical composition comprising brinzolamide

    SENTISS PHARMA PRIVATE LIMITED · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  10. US 11826354

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  11. US 11826405

    Neurotoxin compositions for use in treating headache

    Aeon Biopharma, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  12. US 11826408

    CD200 inhibitors and methods of use thereof

    Regents of the University of Minnesota · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  13. US 11826422

    Methods and compositions for adaptive immune modulation

    The Board of Regents of the University of Texas System · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  14. US 11826415

    Method of conferring a protective immune response to Norovirus

    Takeda Vaccines, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  15. US 11826469

    Polymer particles for neutrophil injury

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  16. US 11826464

    Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  17. US 11827900

    Engineered target specific nucleases

    Sangamo Therapeutics, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  18. US 11827678

    Articles comprising a silk polypeptide for antigen delivery

    Ludwig-Maximilians-Universitat Munchen · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  19. US 11827637

    Azaindole derivatives and their use as ERK kinase inhibitors

    AGV Discovery · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  20. US 11827601

    Heterocyclic NMDA antagonists

    Takeda Pharmaceutical Company Limited · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  21. US 11827686

    Masked cytokine polypeptides

    Xilio Development, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  22. US 11827687

    Synthetic somatostatin receptor ligands

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  23. US 11826315

    STAT3 inhibitors

    Tvardi Therapeutics, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  24. US 11827690

    ApoC-II mimetic peptides

    United State of America, As Represented by the Secretary, Dept. of Health and Human Services · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.